Assessing Angelalign Technology’s Valuation After Strong Earnings And Special Dividend Announcement

Why Angelalign Technology’s latest earnings and dividends matter for investors

Angelalign Technology (SEHK:6699) has drawn fresh attention after releasing full year 2025 earnings, alongside a proposed special dividend of HK$4.99 per share and affirming its regular annual payout.

See our latest analysis for Angelalign Technology.

Since these results and dividend announcements, the share price has gained momentum, with a 30 day share price return of 11.71%, a year to date share price return of 27.67%, and a 1 year total shareholder return of 60.80%, although the 3 year total shareholder return is still negative at 32.63%.

If this combination of earnings, dividends and price strength has you looking beyond a single name, it can be useful to scan other opportunities using the 94 top founder-led companies

With stronger reported earnings, a sizeable special dividend and a share price that already reflects big recent gains, the key question now is whether Angelalign still trades at a discount or if the market is already pricing in future growth.

Price to Earnings of 59.6x: Is it justified?

Angelalign Technology currently trades on a P/E of 59.6x, which is high relative to peers, and this sits against a last close of HK$77.75.

The P/E ratio compares the share price to earnings per share, so a higher P/E usually reflects the market paying more today for each unit of current earnings. For a company like Angelalign, operating in clear aligners and dental services, investors often look at P/E alongside earnings quality and growth expectations to decide whether that premium makes sense.

Here, the tension is clear. Angelalign has high quality earnings, profit growth over the past year of 134.7%, and earnings expected to grow around 24% per year, yet the current P/E of 59.6x is well above both the Hong Kong Medical Equipment industry average of 17.3x and the peer average of 28.7x. Compared to an estimated fair P/E of 18.9x, the current multiple stands at more than triple the level the market could move towards if enthusiasm cools or growth expectations are reassessed.

Explore the SWS fair ratio for Angelalign Technology

Result: Price to Earnings of 59.6x (OVERVALUED)

However, risks remain, including a high P/E that could compress if sentiment cools, and a three-year total shareholder return that is still negative.

Find out about the key risks to this Angelalign Technology narrative.

Another view on Angelalign’s value

While the current P/E of 59.6x looks rich, the SWS DCF model points in the other direction, with an estimated value of HK$89.65 per share versus the HK$77.75 market price, implying around 13.3% upside. When one model flags overvaluation and another suggests a discount, which signal matters more to you?

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Angelalign Technology for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 241 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

If this mix of strong recent returns and valuation debate leaves you unsure, take a close look at the numbers yourself and decide quickly where you stand. To weigh both sides of the story, start by checking the 3 key rewards and 2 important warning signs

Looking for more investment ideas?

If Angelalign has your attention, do not stop here. The right watchlist comes from comparing several quality ideas side by side, not backing a single story.

• Target potential mispricing by reviewing companies that appear attractively valued on strong fundamentals through the 241 high quality undervalued stocks.
• Strengthen your income focus by scanning for reliable high yield opportunities using the 485 dividend fortresses.
• Prioritize resilience by checking companies that score well on financial stability with the 287 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com